James Melvin, MD
Orthopaedic Surgery · Chevy Chase, MDNPI 1124188776
Payments from drug & device makers
Across 30 payments — averaging $125.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$3K
- Molnlycke Health Care US, LLC$451
- Smith+Nephew$138
- Johnson & Johnson$131
- Engage Uni, LLC$114
- Restor3d, Inc.$102
- plus $260 from 8 others
What the payments were for
- Travel & lodging$98126%
- Food & beverage$1,44938%
- Education$1,22132%
- Gifts$1143%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 13 | $2,570 |
| Molnlycke Health Care US, LLC | 1 | $451 |
| Smith+Nephew | 3 | $138 |
| Johnson & Johnson | 3 | $131 |
| Engage Uni, LLC | 1 | $114 |
| Restor3d, Inc. | 1 | $102 |
| KCI USA, Inc. | 1 | $96 |
| Bioventus LLC | 1 | $36 |
| Supreme Orthopedic Systems, LLC | 1 | $26 |
| Siemens Medical Solutions USA, Inc. | 1 | $26 |
| Lifenet Health | 1 | $25 |
| Heraeus Medical, LLC. | 1 | $20 |
| Medical Device Business Services, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Avenir$921
- ROSA-Knee$617
- Mepilex Border Post Op AG$451
- Comprehensive Anatomic$347
- ROSA$149
- Persona$131
- Comprehensive Reverse$126
- Engage Partial Knee System$114
How this compares
$3,765 in reported general payments places this provider in the 55th percentile of 378 orthopaedic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 66 | $1,416 |
| Amoxicillin | 142 | $388 |
| Meloxicam | 68 | $312 |
| Tramadol Hcl | 63 | $286 |
| Diclofenac Sodium | 19 | $276 |
| Doxycycline Hyclate | 33 | $192 |
| Methylprednisolone | 14 | $102 |
| Zolpidem Tartrate | 16 | $99 |
| Oxycodone Hcl | 22 | $97 |
| Clindamycin Hcl | 22 | $81 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Chevy Chase
- Gautam SiramChevy Chase$338K
- Tushar PatelChevy Chase$295K
- Michael GoldsmithChevy Chase$70K
- Laura KeelingChevy Chase$31K
- Mark MyersonBaltimore$10.5M
- David DaluryTowson$8.1M
- Anand MurthiBaltimore$5.4M
- Timothy CoddTowson$3.7M
- Khaled KebaishBaltimore$3.5M
- Hamid HassanzadehBethesda$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.